BOSENTIME 62.5: Bosentan (62.5mg) for Pulmonary Hypertension"

BOSENTIME 62.5 

Bosentan (62.5mg)

Introduction to Bosentan (62.5mg)

BOSENTIME 62.5, containing Bosentan (62.5mg), is an advanced medication designed to manage pulmonary arterial hypertension (PAH). By targeting the underlying mechanisms of PAH, Bosentan helps improve exercise capacity and slow the progression of the disease.

How BOSENTIME 62.5 Works

Bosentan is an endothelin receptor antagonist that works by blocking the action of endothelin-1, a substance in the blood that causes blood vessels to constrict and narrow. By inhibiting endothelin-1, Bosentan helps to relax and widen the blood vessels in the lungs, reducing blood pressure and improving blood flow.

Uses of Bosentan (62.5mg)

BOSENTIME 62.5 is primarily used for:

• Treatment of pulmonary arterial hypertension (PAH)
• Improving exercise capacity in patients with PAH
• Slowing the progression of PAH and enhancing the quality of life

Dosage and Administration

The typical starting dose of BOSENTIME 62.5 is one tablet taken twice daily, in the morning and evening. The dosage may be adjusted based on the patient's response and specific medical conditions. It is important to follow the healthcare provider's instructions carefully.

Potential Side Effects

While BOSENTIME 62.5 is generally well-tolerated, some patients may experience side effects, including:

• Headache
• Flushing
• Edema (swelling)
• Liver function abnormalities
• Anemia

Precautions and Warnings

Before starting BOSENTIME 62.5, patients should inform their healthcare provider about any existing medical conditions, particularly:

• Liver problems
• Anemia or other blood disorders
• Allergies to any component of the medication

Pregnant women should avoid using BOSENTIME 62.5 due to potential risks to the fetus. Women of childbearing potential should use reliable contraception during treatment and for a month after stopping the medication.

Conclusion

BOSENTIME 62.5, with Bosentan (62.5mg), offers significant benefits for managing pulmonary arterial hypertension. By improving exercise capacity and reducing symptoms, this medication helps enhance the quality of life for PAH patients. Always consult with a healthcare provider for personalized advice and treatment plans.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW